The Impact of Androgens and Prolactin on Male Sexual Desire

Influence of Testosterone on Libido and Male Sexual Drive

In clinical sexology practice, androgens—led by testosterone—constitute the key biological factor in the modulation and maintenance of male sexual desire.

Testosterone acts at the brain level by sensitizing the neurochemical structures involved in erotic motivation, initiative, and the processing of erotic stimuli.

With aging or the presence of metabolic disorders, a progressive decline in free androgens is observed, a phenomenon directly related to the onset of hypoactive sexual desire disorder.

A deficiency of this hormone not only leads to a drastic decline in erotic fantasies but also to asthenia, loss of muscle tone, and the absence of spontaneous nocturnal erections.

It should be noted that hormone replacement therapy using exogenous testosterone demonstrates therapeutic efficacy when there is true hypogonadism confirmed by repeated morning blood tests, successfully reactivating sexual energy and erotic responsiveness in men without causing unwarranted overstimulation in male patients who are fully eugonadal.

Impact of Hyperprolactinemia on the Inhibition of Sexual Desire

For its part, prolactin exerts a direct inhibitory effect on male sexual function when its serum levels exceed normal physiological ranges.

Hyperprolactinemia acts by suppressing the pulsatile release of gonadotropin-releasing hormone at the hypothalamic level, which triggers a secondary decrease in the synthesis of luteinizing hormone and testosterone.

However, in addition to this indirect pathway, extremely high prolactin levels directly block the central dopaminergic pathways involved in pleasure and reward.

This neuroendocrine mechanism induces a severe loss of sexual desire, erotic apathy, anhedonia, and even concomitant erectile dysfunction.

The causes of elevated prolactin include pituitary adenomas, chronic psychophysical stress, primary hypothyroidism, and the use of neuroleptic or antidepressant medications.

In clinical practice, correcting hyperprolactinemia with dopamine agonists or by adjusting medication significantly restores libido and erectile function in clinically affected male patients.

Neuroendocrine Evaluation and Diagnostic Integration

Sexological eva luation in cases of suspected male hypoactive sexual desire disorder requires a rigorous and systematic neuroendocrine assessment.

The first blood draw should always be performed in the early morning hours, when testosterone reaches its optimal physiological peaks, thereby avoiding diagnostic bias.

It is essential to measure total testosterone, free testosterone, and sex hormone-binding globulin, as changes in protein binding can mask a functional androgen deficiency.

Likewise, the simultaneous measurement of prolactin, luteinizing hormone, and thyrotropin allows for a clear differentiation between primary and secondary hypogonadism and hyperprolactinemia.

The clinical sexologist must integrate these laboratory findings with the patient’s psychogenic, relational, and environmental factors.

This comprehensive approach prevents the unnecessary medicalization of decreased libido caused by relationship conflicts or stress, ensuring an intervention based on scientific evidence.

Summary

Androgens, led by testosterone, are essential for modulating erotic motivation and sexual desire in men. Their deficiency leads to a loss of fantasies, asthenia, and desire disorder.

Hyperprolactinemia blocks the dopaminergic pleasure pathway and suppresses the gonadotropic axis, causing severe inhibition of desire and erectile dysfunction. Its etiology includes psychophysical stress, pituitary adenomas, and the use of various neuroleptic psychotropic medications.

Diagnosis requires morning blood tests for testosterone, prolactin, and gonadotropins, integrating these findings with psychogenic and relational factors. This approach prevents unnecessary medicalization and ensures a sexological and medical intervention that is appropriately tailored to the patient.